Primary care based-clinic to enable a new era in using genetic information to prevent disease.
Amit Khera, MD
Amit Khera, MD
Associate Director, Precision Medicine Unit, Center for Genomics Medicine, MGH
Cardiologist, Corrigan Minehan Heart Center
Departments, Centers, & Programs:
Cardiovascular Disease Prevention Center
25 New Chardon Street
Boston, MA 02114-4774
- MD, University of Pennsylvania School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Cardiovascular Disease, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Khera AV, Won HH, Peloso GM, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578-89.
- Khera AV, Everett BM, Caulfield MP, et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation. 2014;11;129(6):635-42.
- Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364(2):127-35.
- Press Release
- Apr | 29 | 2020
Family History Misses Identifying Individuals with High Genetic Risk of Cardiovascular Disease or Cancer
Certain genetic changes, termed "pathogenic variants," substantially increase risk for cardiovascular disease and cancer—the leading causes of death—but testing to identify individual carriers is not part of current clinical practice.